High-Alert Medications: Strategies for Improving Safety

(10)
High-Alert Medications: Strategies for Improving Safety image
ISBN-10:

1599402092

ISBN-13:

9781599402093

Edition: 1
Released: Dec 31, 2008
Format: Paperback, 124 pages

Description:

Proper management of high-alert medications is more crucial than ever. This new book provides an in-depth, easy-to-understand analysis of how an organization can reduce the likelihood of patient harm associated with anticoagulants, insulin, and other high-risk drugs. A key part of the book focuses on strategies and process designs organizations can employ to improve high-alert medication safety. Additional topics covered in the book include: reasons and benefits of using both high-alert medications and high-alert processes (opiates, sedatives, narcotics, chemotherapy, compounded sterile products, pediatric medications); potential side effects and interactions of high-risk medications; compliance issues and safety precautions; and important components of a medication system: selection, procurement, storage, ordering, dispensing, administering, and monitoring.

Best prices to buy, sell, or rent ISBN 9781599402093




Frequently Asked Questions about High-Alert Medications: Strategies for Improving Safety

You can buy the High-Alert Medications: Strategies for Improving Safety book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $63.93 on Amazon and is available from 5 sellers at the moment.

If you’re interested in selling back the High-Alert Medications: Strategies for Improving Safety book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the High-Alert Medications: Strategies for Improving Safety book, the best buyback offer comes from and is $ for the book in good condition.

Not enough insights yet.

Not enough insights yet.